Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington

Public research footprint of Fred Hutch/University of Washington Cancer Consortium, compiled from the ClinicalTrials.gov public registry.

410

Registered studies

147

Active

Recruiting now

146

Completed

116

Stopped or withdrawn

Most-studied conditions

Hematopoietic and Lymphatic System Neoplasm · Acute Myeloid Leukemia · Myelodysplastic Syndrome · Acute Leukemia of Ambiguous Lineage

Recently updated registry entries

NCT07645651 — Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or… (Not Yet Recruiting)
NCT07739706 — A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01 (Not Yet Recruiting)
NCT07225127 — Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fred Hutch/University of Washington Cancer Consortium?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.